Measure at a Glance
Type: enabled function
Duration: enabled during the entire EHR reporting period
Objective: Implement drug-drug and drug-allergy interaction checks.
Measure: The EP has enabled this functionality for the entire EHR reporting period.
Exclusion: No exclusion.
There are no changes to this objective and measure regardless of when EPs attest to Stage 1 Meaningful Use.
The attestation portal will require the EP to choose yes or no to having enabled this functionality.
Relevant CMS FAQs
None at this time.
CMS' Final Rule
§ 495.6(d)(2) see objective and measure above
§ 170.304(a) Drug-drug, drug-allergy interaction checks